TABLE 1.

Number of subjects administered a live, attenuated ETEC vaccine strain (PTL-002 or PTL-003) or placebo on days 0 and 10a

No. of subjectsTreatment on day:
010
10PTL-002PTL-002
11PTL-003PTL-003
4PlaceboPTL-002
4PlaceboPTL-003
6PTL-002Placebo or not dosedb
5PTL-003Placebo or not dosedc
  • a The placebo was CeraVacx buffer alone.

  • b Includes two subjects who were not dosed on day 10 and one who received PTL-002 on day 10 but did not return for any additional visits.

  • c Includes one subject who was not dosed on day 10.